Mercer Global Advisors
SGYP

Mercer Global Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Mercer Global Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed – – 1237
2019
Q2 		$0 Buy
+10,000
New – ﹤0.01% 1206

Mercer Global Advisors's SGYP Position: Q3 2019 in Review

Mercer Global Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2019, closing a stake of 10,000 shares.

Mercer Global Advisors first reported a position in SGYP in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 1 fund tracked by Wall St. Rank holds SGYP as of Q3 2019.

  • Mercer Global Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2019 after selling out during the quarter.
  • Mercer Global Advisors sold 10,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2019.
  • Mercer Global Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2019 and held it in 1 quarter.
  • Mercer Global Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2019.

Based on Mercer Global Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.